About Organisers Information Registration Fees Accommodation Programme Abstracts
15th Adriatic Neurology Forum 2026
ANF 2026

15th Adriatic Neurology Forum

15–18 October 2026
Amadria Park Grand Hotel 4 Opatijska Cvijeta, Opatija, Croatia

Registration deadline:
Registration is open until 30 September 2026.
Registration Key Information
Download Programme in PDF
Welcome

About the Congress

Dear colleagues, dear friends,

It is our pleasure to cordially invite you to join the 15th Adriatic Neurology Forum, which will be held in Opatija, Croatia, from 15 to 18 October 2026.

The ANF is a traditional gathering of neurologists from the region renowned for its high-quality scientific programme. Distinguished speakers in the fields of epilepsy, multiple sclerosis, stroke, neuromuscular and neurodegenerative diseases will share their experiences with you, complemented by selected hot topics in headache and intensive care.

Traditionally, we particularly encourage our younger colleagues to present their scientific and professional work at the “Young Neurologists Forum”, an integral part of the ANF.

The Forum provides an opportunity for scientific exchange, professional discussion and networking among neurologists and other healthcare professionals from the region.

We look forward to welcoming you to Opatija!

Organising Committee ANF 2026

Organisation

Organisers

Department of Neurology, Dubrava University Hospital
EPISAN

Practical Information

Information

Congress Venue

Amadria Park Grand Hotel 4 Opatijska Cvijeta
Ul. Viktora cara Emina 6
51410 Opatija
Croatia

Official Congress Languages

The official languages of the Congress are Croatian and English. Simultaneous interpretation will not be provided.

Accreditation / CME Credits

The Croatian Medical Chamber will award continuing medical education credits for participation in the Congress.

Exhibition and Satellite Symposia

For information regarding exhibition space reservations, please contact the technical organiser. For satellite symposia enquiries, please contact the congress organiser.

Deadlines

Important Dates

5 September 2026
Abstract submission deadline
15 September 2026
Sponsorship application deadline
30 September 2026
Accommodation booking and registration deadline
30 September 2026
Deadline for submission of promotional materials
Participation

Registration

Registration Deadline

Registration is open until 30 September 2026 at 23:59.

Registration

Online Registration

To participate in the 15th Adriatic Neurology Forum, participants are kindly asked to complete the official online registration form.

After submitting the registration form, participants will receive further information regarding attendance, accommodation and congress organisation.

Fees

Congress Registration Fees

Physicians

Early registration fee
until 1 September 2026

500.00 € + VAT

Late registration fee
from 2 September 2026

600.00 € + VAT

Sponsors

Early registration fee
until 1 September 2026

350.00 € + VAT

Late registration fee
from 2 September 2026

500.00 € + VAT

The Registration Fee Includes

  • access to the scientific programme and exhibition area
  • congress materials
  • certificate of attendance in PDF format

Changes to Services, Participant Names and Invoices

Changes to the participant name in the congress registration, including the name printed on the accreditation badge, as well as changes to selected services, may be made free of charge until 20 September 2026.

After 20 September 2026, each participant name change will be charged 50.00 EUR per change.

Invoice-related amendments are subject to an additional fee of 50.00 EUR per change. We therefore kindly ask participants to enter all registration and invoicing details carefully and accurately.

Stay

Accommodation

Hotel

Amadria Park Grand Hotel 4 Opatijska Cvijeta
Ul. Viktora cara Emina 6
51410 Opatija
Croatia

Accommodation Details

Hotel category: 4-star congress hotel

Stay period: 15–18 October 2026

Accommodation booking deadline: 30 September 2026

Rates

Accommodation Rates

Single Room

double room for single use

197.00 € / night

Double Room

per person

121.50 € / night

The Rate Includes

  • overnight stay with breakfast
  • Wi-Fi
  • VAT

Additional Information

The rate does not include: tourist tax of 1.50 € per person per day

Parking fee: 25.00 € per car per day

Scientific Content

Programme

Programme
15–18 OCTOBER 2026

Thursday, 15 October 2026

15:00 – 17:00
Registration
17:00 – 17:15
OPENING CEREMONY
17:15 – 19:35
CEREBROVASCULAR DISORDERS AND INTENSIVE CARE
Chairs: Z. Poljaković Skurić, R. Raičević, M. Roje Bedeković, S. Rutović
17:15 – 17:35
M. Bralić: The artery is open – why isn't the patient recovering?
17:35 – 17:55
Z. Poljaković Skurić: Complications of Subarachnoid Hemorrhage – Current Insights
17:55 – 18:15
S. Rutović: Think BAD
18:15 – 18:35
H. Budunčević: When should oral anticoagulant therapy be initiated after a stroke?
18:35 – 18:55
T. Breitenfeld, T. Čustović: Oral anticoagulant therapy after intracranial hemorrhage
18:55 – 19:15
M. Roje Bedeković: What are we missing in intracranial hemorrhage (ICH)?
19:15 – 19:35
V. Pasovski: Pharmacoeconomics of Stroke in Serbia

Friday, 16 October 2026 – Sponsored by Eli Lilly

09:00 – 10:20
NEUROMUSCULAR DISORDERS
Chairs: E. Bilić, H. Bilić
09:00 – 09:30
Moderator: E. Bilić;   F. Sacca: Myasthenia Gravis – Treatment update
(Symposium by AstraZeneca)
09:30 – 10:00
E. Bilić, H. Bilić: Friedreich's ataxia treatment: pros and cons (Sponsored workshop by Biogen)
10:00 – 10:20
L. Dežmalj Grbelja: Impact of comorbidities on myasthenia gravis treatment
10:20 – 11:00
NEUROIMMUNOLOGY (Sponsored by Novartis)
Chairs: I. Lazibat, T. Gabelić, T. Bošković Matić, V. Bašić Kes
10:20 – 10:40
M. Knežević: The role of the microbiota in neuroinflammation in multiple sclerosis
10:40 – 11:00
T. Gabelić: New therapeutic options for NMOSD and MOGAD
11:00 – 11:30
Break
11:30 – 13:10
NEUROIMMUNOLOGY (Sponsored by Novartis)
11:30 – 11:50
M. Titlić: The role of evoked potentials in the diagnosis of multiple sclerosis
11:50 – 12:10
I. Bašić: The other face of neuroimmunity
12:10 – 12:40
S. Kiđemet Piskač: Kesimpta + Mayzent: Are we treating the multiple sclerosis we see today or the disease we want to prevent tomorrow? (Symposium by Novartis)
12:40 – 13:10
Sponsored workshop by Merck
13:10 – 14:10
Lunch Break
14:10 – 16:30
HEADACHE (Sponsored by PLIVA)
Chairs: M. Titlić, A. Radojičić, V. Vuković Cvetković, K. Bačić Baronica
14:10 – 14:30
M. Bosnar Puretić: Therapeutic options for refractory headache
14:30 – 14:50
A. Pantović: Facial neuralgic pain – clinical spectrum and therapeutic approach
14:50 – 15:10
V. Vuković Cvetković: Spontaneous intracranial hypotension: from clinical suspicion to the hidden leak
15:10 – 15:40
AQUIPTA® in Migraine Prevention: From Evidence to Everyday Clinical Practice (Sponsored Symposium)
M. Titlić: AQUIPTA®: Improving Outcomes Through Oral Migraine Prevention
I. Milas: From Patient Profile to Treatment Success: Real-World Experience with AQUIPTA®
15:40 – 16:00
M. Bosnar Puretić: AJOVY® in migraine prophylaxis in women: therapeutic continuity from reproductive age to menopause (Sponsored lecture by PLIVA)
16:00 – 16:30
M. Stojić, M. Majdak: Aimovig: Beyond the headache: Contemporary perspectives in migraine treatment (Symposium by Novartis)
16:30 – 18:15
COMORBIDITIES IN NEUROLOGY
Chairs: Z. Poljaković Skurić, S. Jurić
16:30 – 16:45
Z. Poljaković Skurić: Obesity through the lens of a neurologist (Symposium by Eli Lilly)
16:45 – 17:00
M. Matovinović: A new era in the treatment of obesity: GIP/GLP-1 biology and clinical implications (Symposium by Eli Lilly)
17:00 – 17:15
S. Jurić: The invisible burden of the night: sleep apnea and obesity (Symposium by Eli Lilly)
17:15 – 17:35
E. Papić: Treatment of functional neurological disorders
17:35 – 17:55
P. Gulin: Multidisciplinary Approach to Dysphagia – Experience of the Dubrava University Hospital
17:55 – 18:15
P. Danjek: Dysphagia and Neurological Comorbidities: Two Perspectives on the Same Patient
18:15 – 19:15
YOUNG NEUROLOGISTS' FORUM
Chairs: I. Božović, S. Lasić
18:15 – 18:30
B. Ruška: How and When to Test the Autonomic Nervous System
18:30 – 18:45
L. Oštro, J. Košćak Lukač: Psychosis as a Possible Primary Manifestation of Syphilis
19:00 – 19:15
K. Jažić, S. Tomasović: CJD – The Path to Diagnosis

Saturday, 17 October 2026

09:00 – 09:30
EXPERT OPINION
09:00 – 09:30
I. Durlen: Apheresis in neurology – how can a nephrologist help you?
09:30 – 11:25
NEURODEGENERATIVE DISORDERS
Chairs: S. Tomasović, P. Bago Rožanković, V. Vuletić, N. Klepac, N. Dragašević
09:30 – 09:50
N. Klepac: New approaches to Alzheimer disease: where we stand today
09:50 – 10:10
P. Bago Rožanković: Device-aided therapies in Parkinson's disease: when to start and which to choose
10:10 – 10:30
V. Vuletić: The role of genetics in DBS and dystonia
10:30 – 11:00
Break
11:00 – 12:25
NEURODEGENERATIVE DISORDERS
11:00 – 11:20
S. Kostić: From genotype to therapeutic decision-making: the role of ApoE in modern anti-amyloid therapy
11:20 – 11:40
Lj. Vulje: Patient support program for individuals with advanced Parkinson’s disease
11:40 – 11:55
V. Vuletić: Real-World Experience with Produodopa®: Insights from the ROSSINI Study and CHC Rijeka Clinical Practice (Sponsored Symposium)
11:55 – 12:10
P. Bago Rožanković: When Is It Time to Rethink the Treatment Strategy in Advanced Parkinson's Disease? (Sponsored Symposium)
12:10 – 12:25
H. Šarac: 3. Beyond OFF Time: Why 24-Hour Symptom Control Matters in Advanced Parkinson's Disease (Sponsored Symposium)
12:25 – 14:45
EPILEPSY
Chairs: S. Bašić, A. Ristić, D. Sporiš, N. Vojvodić
12:25 – 12:45
V. Šulentić: Reason for epilepsy surgery failure
12:45 – 13:05
N. Vojvodić: Epilepsy and sleep – a bidirectional mechanism
13:05 – 13:25
A. Bujan Kovač: Sex-specific aspects of epilepsy management
13:25 – 13:45
A. Sruk: Epilepsy in the elderly: hidden clues during sleep
13:45 – 14:05
D. Sporiš: Hypermotor seizures – bridging semiology and diagnosis
14:05 – 14:25
Ž. Petelin Gadže: Epidyolex - news in treatment (Sponsored Symposium by Swixx Biopharma)
14:25 – 14:45
I. Bašić: Challenges in the diagnosis of Lennox-Gastaut Syndrome (Sponsored Symposium by Swixx Biopharma)
14:45 – 15:45
Lunch Break
15:45 – 16:45
EPILEPSY
15:45 – 16:05
S. Bašić: Current challenges and future perspectives in epileptology
16:05 – 16:25
A. Ristić: The influence of regulatory agencies on the clinical practice of epileptologists
16:25 – 16:45
M. Malenica: Fintepla (fenfluramine): a new chapter in the treatment of Dravet syndrome and Lennox-Gastaut syndrome (Symposium by Medis Adria)
16:45 – 17:45
YOUNG NEUROLOGISTS' FORUM
Chairs: I. Bašić, I. Šušak Sporiš
16:45 – 17:00
N. Mazalica: Autonomic Dysfunction in Patients with Cerebellar Ataxia
17:00 – 17:15
A. Milovanović: Hereditary Ataxias – The Clinical-Genetic Spectrum in Serbia
17:15 – 17:30
F. Đumbir: Overlap of Autoimmune Neuromuscular Disorders
17:30 – 17:45
A. Meštrović: Persistent Postural-Perceptual Dizziness (PPPD)

Sunday, 18 October 2026

09:00 – 10:00
YOUNG NEUROLOGISTS' FORUM
Chairs: D. Sporiš, S. Bašić
09:00 – 09:15
F. Đerke: Disease – Modifying Therapy in Early Alzheimer's Disease
09:15 – 09:30
S. Lasić: Efficacy of antiparkinsonian infusion therapies in the treatment of non – motor symptoms of advanced Parkinson's disease
09:30 – 09:45
H. Chudy: When Dysphagia Is the Only Symptom – V4 Segment Vertebral Artery Occlusion (A Case Report)
09:45 – 10:00
I. Mrđen: Beyond Goosebumps- Piloerectile Seizures as a Rare Manifestation of Anti-LGI1 Encephalitis
10:00 – 10:15
Break
10:15 – 11:00
YOUNG NEUROLOGISTS' FORUM
10:15 – 10:30
D. Spasojević: Miller Fisher Syndrome with Complete Recovery
10:30 – 10:45
J. Tabančević: Ptosis as a Neurological Warning Sign
10:45 – 11:00
M. Stojković: Brain Death – Neuralgic facial pain
11:00 – 12:15
EPILEPSY WORKSHOP
11:00 – 12:15
S. Bašić, D. Sporiš, A. Ristić: The Pharmacoresistant Epilepsy
12:15 – 12:45
Closing Remarks
Scientific Contributions

Abstracts

Abstract Submission Guidelines

  • Abstracts must be submitted in both Croatian and English. International participants may submit abstracts in English only.
  • The names and surnames of authors and co-authors, affiliations and title are not included in the abstract or manuscript word count.
  • The name of the presenting author should be written in capital letters.
  • The names and surnames of authors and co-authors should be written without academic or professional titles.
  • Please provide the official name and address of each author’s and co-author’s institution in English.
  • Authors and institutions should be linked numerically.
  • Please provide the e-mail address of the first author.
  • Abstracts will not be language-edited. The author is responsible for linguistic and scientific accuracy.
  • The abstract may contain a maximum of 350 words in Croatian and 400 words in English.
  • At the end of the abstract, please include up to three keywords relevant to the submitted work.

Deadlines

The abstract submission deadline is 5 September 2026.

Please observe the stated submission deadlines, as all abstracts must undergo review and approval.

TEHNIČKI ORGANIZATOR
BTRAVEL d.o.o.
vedrana.karkovic@btravel.pro